Page last updated: 2024-11-10

anthramycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5311005
CHEMBL ID39373
SCHEMBL ID4513
MeSH IDM0001309

Synonyms (5)

Synonym
D02952
anthramycin ,
CHEMBL39373
(e)-3-(4,6-dihydroxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl)prop-2-enamide
SCHEMBL4513

Research Excerpts

Overview

Anthramycin is a benzodiazepine alkaloid with potent antitumor and antibiotic activity. It is produced by the thermophilic actinomycete Streptomyces refuineus sbsp.

ExcerptReferenceRelevance
"Anthramycin (ANT) is a member of the pyrolobenzodiazepine family and is a potent cytotoxic agent. "( Topical delivery of anthramycin II. Influence of binary and ternary solvent systems.
Hadgraft, J; Haque, T; Lane, ME; Rahman, KM; Thurston, DE, 2018
)
2.25
"Anthramycin is a benzodiazepine alkaloid with potent antitumor and antibiotic activity produced by the thermophilic actinomycete Streptomyces refuineus sbsp. "( Benzodiazepine biosynthesis in Streptomyces refuineus.
Bachmann, BO; Farnet, CM; Hu, Y; Ntai, I; Phelan, V; Zazopoulos, E, 2007
)
1.78
"Anthramycin (ATM) which is a product of some streptomyces micro-organisms was shown to antagonize the central effects of cholecystokinin (CCK) such as antinociception and satiety and to displace CCK bound to the slices from the brains of mice. "( Cholecystokinin antagonism by anthramycin, a benzodiazepine antibiotic, in the central nervous system in mice.
Koizumi, Y; Kubota, K; Sugaya, K; Toda, M, 1989
)
2.01

Effects

ExcerptReferenceRelevance
"Anthramycin has been shown to produce excision-dependent single and double strand breaks in DNA, both of which appear to persist many hours after removal of the drug from the media."( Reaction of anthramycin with DNA. Biological consequences of DNA damage in normal and xeroderma pigmentosum cell.
Duteau, N; Hurley, LH; Petrusek, RL; Uhlenhopp, EL, 1982
)
1.36

Treatment

ExcerptReferenceRelevance
"When anthramycin-treated cells were however post-treated with caffeine, the cells did not proceed beyond one cycle and exhibited a mitotic block."( Anthramycin-induced sister-chromatid exchange and caffeine potentiation in the chromosomes of Indian muntjac.
Dosik, H; Ved Brat, S; Verma, RS, 1979
)
2.16

Dosage Studied

ExcerptRelevanceReference
" 4 days post dosing ethylmorphine demethylase and aniline hydroxylase activities in liver 9000 g supernatant were depressed from 26 to 76%."( Acute treatment with pyrrolo(1,4)benzodiazepine antitumor antibiotics alters in vitro hepatic drug metabolizing activity in rats.
Atkinson, JE; Lubawy, WC, 1983
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (17)

Assay IDTitleYearJournalArticle
AID145749Compound was evaluated for growth inhibition of ovarian OVCAR-5 cell line in NCI 60-cell line screen2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
A novel approach to the synthesis of cytotoxic C2-C3 unsaturated pyrrolo[2,1-c]benzodiazepines (PBDs) with conjugated acrylyl C2-substituents.
AID167431Compound was evaluated for growth inhibition of renal RXF-393 cell line in NCI 60-cell line screen2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
A novel approach to the synthesis of cytotoxic C2-C3 unsaturated pyrrolo[2,1-c]benzodiazepines (PBDs) with conjugated acrylyl C2-substituents.
AID409958Inhibition of bovine brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID294536Growth inhibition of human NCI 60 cells after 48 hrs by sulforhodamine B assay relative to control2007Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8
Synthesis of a novel C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine-5,11-dione library: effect of C2-aryl substitution on cytotoxicity and non-covalent DNA binding.
AID43999Compound was evaluated for growth inhibition of leukemia CCRF-CEM cell line in NCI 60-cell line screen2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
A novel approach to the synthesis of cytotoxic C2-C3 unsaturated pyrrolo[2,1-c]benzodiazepines (PBDs) with conjugated acrylyl C2-substituents.
AID294535Growth inhibition of human A498 cells after 48 hrs by sulforhodamine B assay relative to control2007Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8
Synthesis of a novel C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine-5,11-dione library: effect of C2-aryl substitution on cytotoxicity and non-covalent DNA binding.
AID80883Compound was evaluated for growth inhibition of colon HCT116 cell line in NCI 60-cell line screen2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
A novel approach to the synthesis of cytotoxic C2-C3 unsaturated pyrrolo[2,1-c]benzodiazepines (PBDs) with conjugated acrylyl C2-substituents.
AID234998Compound was evaluated for total growth inhibition of 60 cell lines in NCI screen2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
A novel approach to the synthesis of cytotoxic C2-C3 unsaturated pyrrolo[2,1-c]benzodiazepines (PBDs) with conjugated acrylyl C2-substituents.
AID214251Compound was evaluated for growth inhibition of central nervous system U251 cell line in NCI 60-cell line screen2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
A novel approach to the synthesis of cytotoxic C2-C3 unsaturated pyrrolo[2,1-c]benzodiazepines (PBDs) with conjugated acrylyl C2-substituents.
AID41580Compound was tested for percentage inhibition of restriction endonuclease BamH1 enzyme at a concentration of 25 uM;Inhibited2004Journal of medicinal chemistry, Feb-26, Volume: 47, Issue:5
Linker length modulates DNA cross-linking reactivity and cytotoxic potency of C8/C8' ether-linked C2-exo-unsaturated pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimers.
AID226444Compound was evaluated for growth inhibition of 60 cell lines in NCI screen2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
A novel approach to the synthesis of cytotoxic C2-C3 unsaturated pyrrolo[2,1-c]benzodiazepines (PBDs) with conjugated acrylyl C2-substituents.
AID103596Compound was evaluated for growth inhibition of breast MCF-7 cell line in NCI 60-cell line screen2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
A novel approach to the synthesis of cytotoxic C2-C3 unsaturated pyrrolo[2,1-c]benzodiazepines (PBDs) with conjugated acrylyl C2-substituents.
AID214602Compound was evaluated for growth inhibition of melanoma UACC-257 cell line in NCI 60-cell line screen2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
A novel approach to the synthesis of cytotoxic C2-C3 unsaturated pyrrolo[2,1-c]benzodiazepines (PBDs) with conjugated acrylyl C2-substituents.
AID409960Inhibition of bovine brain MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID228571Lethal concentration of compound was evaluated against 60 cell lines in NCI screen2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
A novel approach to the synthesis of cytotoxic C2-C3 unsaturated pyrrolo[2,1-c]benzodiazepines (PBDs) with conjugated acrylyl C2-substituents.
AID84354Compound was evaluated for growth inhibition of non-small cell lung HOP-92 cell line in NCI 60-cell line screen2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
A novel approach to the synthesis of cytotoxic C2-C3 unsaturated pyrrolo[2,1-c]benzodiazepines (PBDs) with conjugated acrylyl C2-substituents.
AID156324Compound was evaluated for growth inhibition of prostate PC-3 cell line in NCI 60-cell line screen2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
A novel approach to the synthesis of cytotoxic C2-C3 unsaturated pyrrolo[2,1-c]benzodiazepines (PBDs) with conjugated acrylyl C2-substituents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (106)

TimeframeStudies, This Drug (%)All Drugs %
pre-199054 (50.94)18.7374
1990's23 (21.70)18.2507
2000's14 (13.21)29.6817
2010's14 (13.21)24.3611
2020's1 (0.94)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.56 (24.57)
Research Supply Index4.68 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index81.78 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (51.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews9 (8.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other98 (91.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]